Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Work In Process (2017 - 2023)

Perspective Therapeutics' Work In Process history spans 11 years, with the latest figure at $616000.0 for Q1 2023.

  • On a quarterly basis, Work In Process rose 73.52% to $616000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $616000.0, a 73.52% increase, with the full-year FY2022 number at $636000.0, changed N/A from a year prior.
  • Work In Process hit $616000.0 in Q1 2023 for Perspective Therapeutics, down from $636000.0 in the prior quarter.
  • Over the last five years, Work In Process for CATX hit a ceiling of $636000.0 in Q4 2022 and a floor of $114000.0 in Q1 2019.
  • Historically, Work In Process has averaged $306000.0 across 5 years, with a median of $240000.0 in 2020.
  • Biggest five-year swings in Work In Process: fell 25.49% in 2019 and later skyrocketed 129.1% in 2022.
  • Tracing CATX's Work In Process over 5 years: stood at $166000.0 in 2019, then grew by 26.51% to $210000.0 in 2020, then skyrocketed by 37.14% to $288000.0 in 2021, then surged by 120.83% to $636000.0 in 2022, then fell by 3.14% to $616000.0 in 2023.
  • Business Quant data shows Work In Process for CATX at $616000.0 in Q1 2023, $636000.0 in Q4 2022, and $614000.0 in Q3 2022.